Jean-Luc Teillaud

8PUBLICATIONS
22CO-AUTHORS
Innate immunityTumour immunologyGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 11, 2024
Exploring the Role of Tertiary Lymphoid Structures Using a Mouse Model of Bacteria-Infected Lungs.

Jean-Luc Teillaud, Lucile Regard, Clémence Martin

|Aug 08, 2024
Tertiary lymphoid structures in anticancer immunity.

Jean-Luc Teillaud, Ana Houel, Marylou Panouillot

|Feb 24, 2022
SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma.

Sahar Kassem, Béré K Diallo, Nizar El-Murr

|Feb 11, 2022
BMFPs, a versatile therapeutic tool for redirecting a preexisting Epstein-Barr virus antibody response toward defined target cells.

Benoît Gamain, Carine Brousse, Nathan E Rainey

|Sep 14, 2020
A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy.

Ana Victoria Casadesús, Claire Deligne, Béré Kadjdiatou Diallo

Pageof 2

Frequent Collaborators

2 joint publications

Béré K Diallo

2 joint publications

Marie-Caroline Dieu-Nosjean

1 joint publications

Benoît Gamain

1 joint publications

Carine Brousse